Abiomed Pumps Up Temporary Heart Assist Offerings With AB5000 Ventricle

Abiomed expects FDA's Sept. 25 approval of a PMA supplement for its AB5000 Ventricle biventricular cardiac assist system to help reinvigorate stagnant temporary cardiac assist capital equipment sales